Home Newsfeeds Needham Initiates Coverage On AppLovin with Hold Rating

Needham Initiates Coverage On AppLovin with Hold Rating

Needham analyst Bernie McTernan initiates coverage on AppLovin (NASDAQ:APP) with a Hold rating.

byBenzinga Newsdesk

October 7, 2022

1 minute read

Needham analyst Bernie McTernan initiates coverage on AppLovin (NASDAQ:APP) with a Hold rating.

Nordstrom Reports Weaker Than Expected Holiday Sales: 4 Analysts Weigh In

By AJ Fabino

January 20, 11:14 AM

Nordstrom Inc (NYSE: JWN) reported weaker-than-expected holiday sales on Thursday, leading the company to lower guidance for the fourth quarter and full fiscal year 2022, which ends in late January.

JWN

Royalty Pharma Pens $500M Royalty Agreement With Ferring Pharmaceuticals For New Intravesical Gene Therapy Adstiladrin® (nadofaragene Firadenovec-vncg)

By Benzinga Newsdesk

August 24, 6:33 AM

Royalty Pharma plc and Ferring Pharmaceuticals today announced that Royalty Pharma has acquired a synthetic royalty on US net sales of Ferring's Adstiladrin® (nadofaragene firadenovec-vncg) for up to

RPRX

Salesforce Stock Is Sliding Monday: What’s Going On?

By Adam Eckert

April 15, 8:48 AM

Salesforce is in advanced talks to acquire cloud data management company Informatica, according to a Wall Street Journal report. The takeover price being discussed is currently below Informatica's share price of just over $38.

CRM

Israel-Based Clearmind Successfully Completed Two R&D Projects With The Hebrew University of Jerusalem’s Tech Transfer Company, Yissum

By Benzinga Newsdesk

January 19, 10:16 AM

The two drug-discovery projects for novel, next generation, innovative, patentable psychedelic compounds, are expected to expand Clearmind's IP portfolio Tel Aviv, Israel / Vancouver, Canada, Jan. 19, 2023

CMND

Needham Initiates Coverage On AppLovin with Hold Rating

Related Posts

Nordstrom Reports Weaker Than Expected Holiday Sales: 4 Analysts Weigh In

Royalty Pharma Pens $500M Royalty Agreement With Ferring Pharmaceuticals For New Intravesical Gene Therapy Adstiladrin® (nadofaragene Firadenovec-vncg)

Salesforce Stock Is Sliding Monday: What’s Going On?

Israel-Based Clearmind Successfully Completed Two R&D Projects With The Hebrew University of Jerusalem’s Tech Transfer Company, Yissum